Jeffrey Dunn

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. doi request reprint Impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis
    Jeffrey Dunn
    Stanford Multiple Sclerosis Clinic, Department of Neurology and Neurological Sciences, Stanford University Medical Center, 300 Pasteur Drive H3160, Stanford, CA 94305 5235, USA
    Expert Rev Pharmacoecon Outcomes Res 10:433-40. 2010
  2. doi request reprint Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis
    Jeffrey Dunn
    Stanford Multiple Sclerosis Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, CA 94305 5235, USA
    Curr Med Res Opin 27:1415-23. 2011

Detail Information

Publications2

  1. doi request reprint Impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis
    Jeffrey Dunn
    Stanford Multiple Sclerosis Clinic, Department of Neurology and Neurological Sciences, Stanford University Medical Center, 300 Pasteur Drive H3160, Stanford, CA 94305 5235, USA
    Expert Rev Pharmacoecon Outcomes Res 10:433-40. 2010
    ..This review was conducted to examine the need and impact of caregiving for patients with MS, focusing on the contribution of mobility impairment to loss of patient independence...
  2. doi request reprint Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis
    Jeffrey Dunn
    Stanford Multiple Sclerosis Center, Department of Neurology and Neurological Sciences, Stanford University Medical Center, Stanford, CA 94305 5235, USA
    Curr Med Res Opin 27:1415-23. 2011
    ..Dalfampridine (4-aminopyridine), a voltage-dependent potassium channel blocker, has been shown to improve walking in patients with MS, as demonstrated by an increase in walking speed...